Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

Analysts see China’s latest initiatives injecting at least 1 trillion yuan ($138 billion) of additional flows in 2025 into ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

The firm said preliminary core Q4 2024 revenues are expected to be flat, exceeding prior expectations, while its China business has stabilized and will recover.

At the JPMorgan Healthcare Conference, the European healthcare giant ... vaccine challenges from external pressures in the US and China. The Brentford, U.K.-based company remains confident that ...